Previous 10 | Next 10 |
Acelrx shares plummeted after the company released third quarter earnings. However, numbers were significantly up compared to any prior period. A recently published study shows the excellent prospects of sublingual sufentanil. For further details see: AcelRx Pharmaceutic...
AcelRx Pharmaceuticals to Present at Credit Suisse 29th Annual Virtual Healthcare Conference PR Newswire REDWOOD CITY, Calif., Nov. 6, 2020 REDWOOD CITY, Calif. , Nov. 6, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharm...
Gainers: Aurora Cannabis (ACB) +82%, Sundial Growers (SNDL) +69%, Tilray (TLRY) +36%, OrganiGram Holdings Inc. (OGI) +30%, MEDNAX (MD) +19%.Losers: Assembly Biosciences (ASMB) -69%, Global Blood Therapeutics (GBT) -35%, AcelRx Pharmaceuti...
Assembly Biosciences (ASMB) -55% on Q3 earnings release.Global Blood Therapeutics (GBT) -32% on Q3 earnings release.Epizyme (EPZM) -23% on Q3 earnings release.Marin Software (MRIN) -14% on Q3 earnings release.Hall of Fame Resort & Entertainment (HOF...
AcelRx Pharmaceuticals, Inc. (ACRX) Q3 2020 Earnings Conference Call November 05, 2020, 04:30 PM ET Company Participants Raffi Asadorian - Chief Financial Officer Vincent Angotti - Chief Executive Officer & Director Pamela Palmer - Co-Founder, Chief Medical Officer & Director Conferen...
AcelRx Pharmaceuticals (ACRX): Q3 GAAP EPS of -$0.10 misses by $0.02.Revenue of $1.4M (+129.5% Y/Y) misses by $1.43M.Cash & equivalents $43.0M.The Zimmer Biomet collaboration and addition of DSUVIA to the U.S. Department of Defense Joint Deployment Formulary and the U.S. Army contract hig...
AcelRx Pharmaceuticals Reports Third Quarter 2020 Financial Results Third quarter product sales of $1.3M, up significantly compared to $0.3M in the second quarter The Zimmer Biomet collaboration, addition of DSUVIA® to the U.S. Department of Defense Joint Deployment For...
AcelRx to Host Third Quarter 2020 Financial Results Call and Webcast on Thursday, November 5, 2020 PR Newswire REDWOOD CITY, Calif., Oct. 29, 2020 REDWOOD CITY, Calif. , Oct. 29, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty ph...
Penny Stocks to Watch for Mid-October Penny stocks are some of the easiest ways to make sizable gains in the stock market today. On the other hand, they can also lead to big losses if investors aren’t careful. But, when searching for a penny stock to buy , we can use ...
These Penny Stocks Are Seeing Positive Performance Penny stocks are defined as equities trading under $5. These low-cost stocks provide an easier way for new investors to enter the market due to their price. In 2020, people have been seeking new revenue streams due to the hardships ...
News, Short Squeeze, Breakout and More Instantly...
AcelRx Pharmaceuticals Inc. Company Name:
ACRX Stock Symbol:
NASDAQ Market:
AcelRx Pharmaceuticals Inc. Website:
AcelRx Announces Rebranding With Name Change to Talphera, Inc. PR Newswire Name change to "Talphera" reflects a new era of the Company in partnership with the medical community developing novel solutions for medically supervised settings Talphera will begin trading on ...
AcelRx Pharmaceuticals Announces Publication of Study Evaluating Anticoagulation Practices for Continuous Renal Replacement Therapy in the United States PR Newswire Use of CRRT increased during COVID and remained at these higher utilization levels Study results demonst...
AcelRx Reports Third Quarter 2023 Financial Results and Provides Corporate Update PR Newswire Niyad™ Investigational Device Exemption (IDE) approval by the FDA achieved in third quarter Company plans to begin its Niyad registrational study this quarter with topl...